708 related articles for article (PubMed ID: 31608277)
1. Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives.
Singh A; Gupta S; Sachan M
Front Cell Dev Biol; 2019; 7():182. PubMed ID: 31608277
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers in the diagnosis of ovarian cancer.
Bijron JG; Bol GM; Verheijen RH; van Diest PJ
Expert Opin Med Diagn; 2012 Sep; 6(5):421-38. PubMed ID: 23480807
[TBL] [Abstract][Full Text] [Related]
3. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
Terp SK; Stoico MP; Dybkær K; Pedersen IS
Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Diagnostic Potential of Candidate Hypermethylated Genes in Epithelial Ovarian Cancer in North Indian Population.
Singh A; Gupta S; Sachan M
Front Mol Biosci; 2021; 8():719056. PubMed ID: 34778370
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer: epigenetics, drug resistance, and progression.
Xie W; Sun H; Li X; Lin F; Wang Z; Wang X
Cancer Cell Int; 2021 Aug; 21(1):434. PubMed ID: 34404407
[TBL] [Abstract][Full Text] [Related]
6. Early Epigenetic Markers for Precision Medicine.
Dumitrescu RG
Methods Mol Biol; 2018; 1856():3-17. PubMed ID: 30178243
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer detection by DNA methylation in cervical scrapings.
Wu TI; Huang RL; Su PH; Mao SP; Wu CH; Lai HC
Clin Epigenetics; 2019 Nov; 11(1):166. PubMed ID: 31775891
[TBL] [Abstract][Full Text] [Related]
8. Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?
Robotti M; Scebba F; Angeloni D
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979630
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Modifications as Biomarkers of Tumor Development, Therapy Response, and Recurrence across the Cancer Care Continuum.
Thomas ML; Marcato P
Cancers (Basel); 2018 Apr; 10(4):. PubMed ID: 29614786
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic biomarkers in epithelial ovarian cancer.
Gloss BS; Samimi G
Cancer Lett; 2014 Jan; 342(2):257-63. PubMed ID: 22245949
[TBL] [Abstract][Full Text] [Related]
11. Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer.
Chen Q; Zhang ZH; Wang S; Lang JH
Onco Targets Ther; 2019; 12():11517-11530. PubMed ID: 31920340
[TBL] [Abstract][Full Text] [Related]
12. Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?
Hentze JL; Høgdall CK; Høgdall EV
Mol Clin Oncol; 2019 Mar; 10(3):323-330. PubMed ID: 30847169
[TBL] [Abstract][Full Text] [Related]
13. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
14. Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.
El Bairi K; Kandhro AH; Gouri A; Mahfoud W; Louanjli N; Saadani B; Afqir S; Amrani M
Cell Oncol (Dordr); 2017 Apr; 40(2):105-118. PubMed ID: 27981507
[TBL] [Abstract][Full Text] [Related]
15. Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature.
Guo XM; Miller H; Matsuo K; Roman LD; Salhia B
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33671298
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic Biomarkers for Risk Assessment of Particulate Matter Associated Lung Cancer.
Bhargava A; Bunkar N; Aglawe A; Pandey KC; Tiwari R; Chaudhury K; Goryacheva IY; Mishra PK
Curr Drug Targets; 2018; 19(10):1127-1147. PubMed ID: 28891455
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
18. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
19. Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids.
Lewis JM; Heineck DP; Heller MJ
Expert Rev Mol Diagn; 2015; 15(9):1187-200. PubMed ID: 26189641
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing Approach in Methylation Analysis of HNF1B and GATA4 Genes: Searching for Biomarkers in Ovarian Cancer.
Bubancova I; Kovarikova H; Laco J; Ruszova E; Dvorak O; Palicka V; Chmelarova M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
